PIEDMONT INVESTMENT ADVISORS INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$264,000
-54.2%
9,190
+1.1%
0.01%
-50.0%
Q4 2019$576,000
+2642.9%
9,087
+501.4%
0.02%
+1900.0%
Q2 2018$21,0001,5110.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders